Mark J. Holdbrook - Net Worth and Insider Trading
Mark J. Holdbrook Net Worth
The estimated net worth of Mark J. Holdbrook is at least $110,121 dollars as of 2024-09-20. Mark J. Holdbrook is the V.P., Clinical Affairs of Tarsus Pharmaceuticals Inc and owns about 3,191 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $110,121. Details can be seen in Mark J. Holdbrook's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J. Holdbrook has not made any transactions after 2023-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J. Holdbrook
Mark J. Holdbrook Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J. Holdbrook owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Mark J. Holdbrook’s form 4 insider trades.
Insider Ownership Summary of Mark J. Holdbrook
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-03-20 | V.P. & Clinical Affairs |
Mark J. Holdbrook Latest Holdings Summary
Mark J. Holdbrook currently owns a total of 1 stock. Mark J. Holdbrook owns 3,191 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 20, 2023, with a value of $110,121.
Latest Holdings of Mark J. Holdbrook
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-03-20 | 3,191 | 34.51 | 110,121 |
Holding Weightings of Mark J. Holdbrook
Mark J. Holdbrook Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J. Holdbrook has made a total of 2 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 386 shares on March 20, 2023, which brought Mark J. Holdbrook around $4,995.
Insider Trading History of Mark J. Holdbrook
- 1
Mark J. Holdbrook Trading Performance
Mark J. Holdbrook Ownership Network
Mark J. Holdbrook Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Mark J. Holdbrook is the V.P. & Clinical Affairs of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Mark J. Holdbrook made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 262,970 shares made by Bobak R. Azamian , a net sale of 12,987 shares made by Aziz Mottiwala , and a net sale of 13,870 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 35,000 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 35,000 shares. During the past 18 months, 366,338 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 355,832 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Mark J. Holdbrook Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J. Holdbrook. You might contact Mark J. Holdbrook via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
